Literature DB >> 14691053

Oleamide: a member of the endocannabinoid family?

Christopher J Fowler1.   

Abstract

The fatty acid amide class of compounds, which include the endocannabinoid anandamide and the sleep-inducing compound oleamide, have been shown in vitro to have a multiplicity of actions upon different neurochemical systems. In the present issue of this journal, Leggett et al present data indicating that oleamide functionally activates CB(1) cannabinoid receptors in vitro. The significance of their finding is discussed in this commentary.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14691053      PMCID： PMC1574195          DOI： 10.1038/sj.bjp.0705608

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  11 in total

1.  CB1 cannabinoid receptors and on-demand defense against excitotoxicity.

Authors:  Giovanni Marsicano; Sharon Goodenough; Krisztina Monory; Heike Hermann; Matthias Eder; Astrid Cannich; Shahnaz C Azad; Maria Grazia Cascio; Silvia Ortega Gutiérrez; Mario van der Stelt; Maria Luz López-Rodriguez; Emilio Casanova; Günther Schütz; Walter Zieglgänsberger; Vincenzo Di Marzo; Christian Behl; Beat Lutz
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

2.  The sleep inducing factor oleamide is produced by mouse neuroblastoma cells.

Authors:  T Bisogno; N Sepe; L De Petrocellis; R Mechoulam; V Di Marzo
Journal:  Biochem Biophys Res Commun       Date:  1997-10-20       Impact factor: 3.575

Review 3.  Anandamide: some like it hot.

Authors:  V Di Marzo; T Bisogno; L De Petrocellis
Journal:  Trends Pharmacol Sci       Date:  2001-07       Impact factor: 14.819

Review 4.  Cannabinoids and pain.

Authors:  A S Rice
Journal:  Curr Opin Investig Drugs       Date:  2001-03

5.  'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism.

Authors:  Darren Smart; Kent-Olov Jonsson; Séverine Vandevoorde; Didier M Lambert; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 6.  Endocannabinoid signaling in the brain.

Authors:  Rachel I Wilson; Roger A Nicoll
Journal:  Science       Date:  2002-04-26       Impact factor: 47.728

Review 7.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

8.  Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.

Authors:  James D Leggett; S Aspley; S R G Beckett; A M D'Antona; D A Kendall; D A Kendall
Journal:  Br J Pharmacol       Date:  2004-01-05       Impact factor: 8.739

9.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.

Authors:  Jin Fu; Silvana Gaetani; Fariba Oveisi; Jesse Lo Verme; Antonia Serrano; Fernando Rodríguez De Fonseca; Anja Rosengarth; Hartmut Luecke; Barbara Di Giacomo; Giorgio Tarzia; Daniele Piomelli
Journal:  Nature       Date:  2003-09-04       Impact factor: 49.962

10.  Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.

Authors:  Aron H Lichtman; E Gregory Hawkins; Graeme Griffin; Benjamin F Cravatt
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030
View more
  15 in total

Review 1.  Astonishing diversity of natural surfactants: 4. Fatty acid amide glycosides, their analogs and derivatives.

Authors:  Valery M Dembitsky
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

2.  Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.

Authors:  Pui Man Hoi; C Robin Hiley
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

Review 3.  New approaches and challenges to targeting the endocannabinoid system.

Authors:  Vincenzo Di Marzo
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

Review 4.  The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Authors:  Emma L Scotter; Mary E Abood; Michelle Glass
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 5.  The expanding field of cannabimimetic and related lipid mediators.

Authors:  Heather B Bradshaw; J Michael Walker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

6.  A Cannabinoid Receptor-Mediated Mechanism Participates in the Neuroprotective Effects of Oleamide Against Excitotoxic Damage in Rat Brain Synaptosomes and Cortical Slices.

Authors:  Marisol Maya-López; Leonardo C Rubio-López; Ivana V Rodríguez-Alvarez; Julián Orduño-Piceno; Yuliza Flores-Valdivia; Aline Colonnello; Edgar Rangel-López; Isaac Túnez; Oscar Prospéro-García; Abel Santamaría
Journal:  Neurotox Res       Date:  2019-07-08       Impact factor: 3.911

Review 7.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 8.  Gut microbial metabolites associated with HIV infection.

Authors:  Zheng Wang; Qibin Qi
Journal:  Future Virol       Date:  2019-05-15       Impact factor: 1.831

Review 9.  On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.

Authors:  Karen Jaqueline Paredes-Ruiz; Karla Chavira-Ramos; Mario Orozco-Morales; Cimen Karasu; Alexey A Tinkov; Michael Aschner; Abel Santamaría; Ana Laura Colín-González
Journal:  Neurotox Res       Date:  2021-11-06       Impact factor: 3.911

Review 10.  The therapeutic potential of novel cannabinoid receptors.

Authors:  Faith R Kreitzer; Nephi Stella
Journal:  Pharmacol Ther       Date:  2009-02-25       Impact factor: 12.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.